Health and Fitness Health and Fitness
Wed, December 1, 2010
[ Wed, Dec 01st 2010 ] - Market Wire
Bristol-Myers Squibb and Alvin Ailey American Dan .. -Its-Kind Collaboration to Express the Stories of
[ Wed, Dec 01st 2010 ] - Market Wire
Oncolytics Biotech® Inc. Announces Start of .. lment in Randomized Phase II Ovarian Cancer Study
[ Wed, Dec 01st 2010 ] - Market Wire
Medisafe 1 Technologies Locking Syringe Adds ERP Compatibility Feature
[ Wed, Dec 01st 2010 ] - Market Wire
Aetna Names Michael Mathias Chief Information Officer
[ Wed, Dec 01st 2010 ] - Market Wire
CytRx Initiating Phase 2b Clinical Trial with Tamibarotene in Advanced Lung Cancer
[ Wed, Dec 01st 2010 ] - Market Wire
Genzyme Completes Sale of Genetic Testing Business to LabCorp
[ Wed, Dec 01st 2010 ] - Market Wire
LabCorp Successfully Completes Acquisition of Genzyme Genetics
[ Wed, Dec 01st 2010 ] - Market Wire
Synovis Life Technologies Reports 21 Percent Year .. ear Revenue Growth for Fiscal 2010 Fourth Quarter
[ Wed, Dec 01st 2010 ] - Market Wire
Allos Therapeutics Announces FOLOTYN® Data to Be .. t the 2010 Chicago Multidisciplinary Symposium in
[ Wed, Dec 01st 2010 ] - Market Wire
MEDNAX Announces the Acquisition of Washington State Pediatric Critical Care Practice
[ Wed, Dec 01st 2010 ] - Market Wire
BioScrip Appoints David W. Froesel, Jr. as Execut .. President, Chief Financial Officer and Treasurer
[ Wed, Dec 01st 2010 ] - Market Wire
OSI Pharmaceuticals, Inc. Exercises Option under .. nd Translational Research Collaboration with AVEO
Tue, November 30, 2010
[ Tue, Nov 30th 2010 ] - Market Wire
Teva Announces $1 Billion Share Repurchase Program
[ Tue, Nov 30th 2010 ] - Market Wire
NeuroMetrix to Present at Canaccord Genuity 5th Cardiovascular, Diabetes & Obesity Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Gilead Sciences to Present at the NASDAQ OMX 25th Investor Program
[ Tue, Nov 30th 2010 ] - Market Wire
HealthSpring, Inc. Completes Acquisition of Bravo Health, Inc.
[ Tue, Nov 30th 2010 ] - Market Wire
InSite Vision Names Timothy Ruane Chief Executive Officer
[ Tue, Nov 30th 2010 ] - Market Wire
Micromet to Present at the 2010 Piper Jaffray Healthcare Conference
[ Tue, Nov 30th 2010 ] - Market Wire
Spectranetics to Present at the 5th Annual Canacc .. ular, Diabetes & Obesity Conference on December 7
[ Tue, Nov 30th 2010 ] - Market Wire
Ruim 260 presentaties en posters over producten v .. tijdens 52ste jaarvergadering van American Societ
[ Tue, Nov 30th 2010 ] - Market Wire
Merck KGaA, Teva Pharmaceuticals Industries, Biogen Idec, Elan and POSCO
[ Tue, Nov 30th 2010 ] - Market Wire
NewGene Ltd. Achieves Certification to Provide NimbleGen Sequence Capture Services in UK
[ Tue, Nov 30th 2010 ] - Market Wire
Seattle Genetics Announces Additions to Commercial Leadership Team
[ Tue, Nov 30th 2010 ] - Market Wire
Zynex, Inc. Appoints President of Subsidiary, Zynex NeuroDiagnostic
[ Tue, Nov 30th 2010 ] - Market Wire
AOAC Certifies SDIX Salmonella 24-hour Test System for Food Processing Environmental Testing
[ Tue, Nov 30th 2010 ] - Market Wire
Array BioPharma Achieves Clinical Milestone in Celgene Collaboration
[ Tue, Nov 30th 2010 ] - Market Wire
Viral Genetics Announces Initiation of Research Coverage by Research 2.0
[ Tue, Nov 30th 2010 ] - Market Wire
Ms de 260 presentaciones y sesiones que evalan lo .. estacadas durante la 52 edicin de la reunin anual
[ Tue, Nov 30th 2010 ] - Market Wire
International Stem Cell Corporation Announces Com .. ic of Its Breakthrough Stem Cell-Based Lines of S
[ Tue, Nov 30th 2010 ] - Market Wire
La 52a riunione annuale dell'American Society of .. presentazioni e poster per la valutazione dei pro

La 52a riunione annuale dell'American Society of Hematology proporr oltre 260 presentazioni e poster per la valutazione dei pro


Published on 2010-11-30 04:46:23 - Market Wire
  Print publication without navigation


BOUDRY, Svizzera--([ BUSINESS WIRE ])--Celgene International Srl (NASDAQ: CELG) ha annunciato oggi che, in occasione della 52a riunione annuale della™American Society of Hematology prevista a Orlando, in Florida, dal 4 al 7 dicembre, ricercatori clinici di primari centri di ricerca sul cancro presenteranno i dati emersi da sperimentazioni recenti e in corso, proponendo oltre 260 poster e presentazioni, tra cui oltre 65 interventi nei quali sar effettuata una valutazione dei prodotti Celgene per i tumori del sangue.

Per ulteriori informazioni, visitare il sito web [ www.hematology.org ].

Informazioni su Celgene International Srl

Celgene International Srl, con sede a Boudry, nel cantone di Neuchtel (Svizzera), una societ interamente controllata ed la sede internazionale di Celgene Corporation.

Il testo originale del presente annuncio, redatto nella lingua di partenza, la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodit del lettore e devono rinviare al testo in lingua originale, che l'unico giuridicamente valido.

Contributing Sources